Making the Invisible Visible
in Medical Device Innovation

ReVanta is an AI-enabled opportunity discovery platform for medical device innovation. We help medical device organizations uncover overlooked opportunities for growth, partnerships, and commercialization—without starting from scratch.

A sleek, modern, cylinder-shaped device with a metallic silver finish and rounded edges, placed on a neutral surface with soft lighting.

The Opportunity

Medical device innovation doesn’t always require building something new. Often, the biggest breakthroughs come from seeing what already exists—differently.

Billions in value hide across the medical device industry: devices operating in isolation that could integrate, technologies approved for one use that could serve many, proven innovations left for dead that could save lives.

ReVanta helps organizations uncover opportunities hiding in plain sight:

  • Underused technologies with room to expand

  • Strong assets that could create more value together

  • Research that deserves a second look—and a clearer path forward

What ReVanta Reveals

ReVanta helps surface opportunities such as:

  • Strategic partnerships that unlock new value

  • Portfolio expansion paths aligned to real clinical needs

  • Integration opportunities that improve outcomes and usability

  • Second-life innovation that deserves redeployment

Ready to see what’s been hiding in plain sight?

If you’re exploring portfolio growth, patent extension, partnerships, or commercialization opportunities, we’d love to talk.

FAQs

Is ReVanta software or service?

Both! Today, it’s delivered through focused engagements with partner organizations. The platform is being developed alongside early partners.


Do you need access to confidential data?

Not to begin. We can start with portfolio context and relevant public information, then align on deeper inputs if needed.


Why is now the time for ReVanta's solution?

AI technology is sophisticated enough for complex medical device analysis, healthcare economics create urgent demand for cost-effective innovation, and the regulatory environment are more favorable to adaptive pathways and real-world evidence.


Who are the ideal founding partners?

Multi-portfolio device manufacturers with diverse product lines across therapeutic areas. Companies facing patent cliffs within 3-5 years on major revenue-generating devices. Organizations with shelved technologies or clinical trials from past R&D investments. Forward-thinking leadership that embraces AI-powered strategic decision-making. $500M-10B annual revenue range with established market position.